Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
National Institutes of Health Clinical Center (CC)
BioNTech SE
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
OncoC4, Inc.
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Imugene Limited
AstraZeneca
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
University of Florida
DualityBio Inc.